ArticleTranslational breast cancer research : a journal focusing on translational research in breast cancer2025

Real-world efficacy and safety of trastuzumab deruxtecan in heavily pre-treated HER2-low metastatic breast cancer across distinct immunohistochemistry statuses.

Song Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.